Skip to Content

Clinical Trials Search Results

Showing 1-2 of 2

Sorted By:

  • ACCRU RU011201I

    A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.

  • Novartis CRAD001Y24135

    An open-label, Phase II Single-Arm study of Everolimus in combination with Letrozole in the treatment of postmenopausal women with estrogen receptor positive Metastatic Breast Cancer

Showing trials 1-2 of 2

Also in this Section